Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharon Marsh

Showing results (61-70 of 88) with videos related to

Pageof 9
Sort By:
Pharmacogenetics and Genomics|November 5, 2010
Doxorubicin pathways: pharmacodynamics and adverse effectsCaroline F Thorn, Connie Oshiro, Sharon Marsh, et al.
Pharmacogenetics and Genomics|February 13, 2010
Cytochrome P450 2C9-CYP2C9Derek Van Booven, Sharon Marsh, Howard McLeod, et al.
Pharmacogenomics|April 29, 2015
Pharmacogenomic assessment of Mexican and Peruvian populationsSharon Marsh, Cristi R King, Derek J Van Booven, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2004
ABCG2 pharmacogenetics: ethnic differences in allele frequency and assessment of influence on irinotecan dispositionFloris A de Jong, Sharon Marsh, Ron H J Mathijssen, et al.
Genomics|October 12, 2004
Pharmacogenomic assessment of carboxylesterases 1 and 2Sharon Marsh, Ming Xiao, Jinsheng Yu, et al.
Clinical Pharmacology and Therapeutics|July 2, 2004
Diflomotecan pharmacokinetics in relation to ABCG2 421C>A genotypeAlex Sparreboom, Hans Gelderblom, Sharon Marsh, et al.
Oncology Reports|April 12, 2011
The NQO1*2/*2 polymorphism is associated with poor overall survival in patients following resection of stages II and IIIa non-small cell lung cancerJill M Kolesar, Suzanne E Dahlberg, Sharon Marsh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2003
Irinotecan pathway genotype analysis to predict pharmacokineticsRon H J Mathijssen, Sharon Marsh, Mats O Karlsson, et al.
Pharmacogenetics and Genomics|April 3, 2009
Association of thymidylate synthase variants with 5-fluorouracil cytotoxicityEric J Peters, Aldi T Kraja, Shiow J Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2006
DNA repair pathway profiling and microsatellite instability in colorectal cancerJinsheng Yu, Mary A Mallon, Wanghai Zhang, et al.
Pageof 9

Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
Pharmacogenetics and Genomics|November 5, 2010
Doxorubicin pathways: pharmacodynamics and adverse effectsCaroline F Thorn, Connie Oshiro, Sharon Marsh, et al.
Pharmacogenetics and Genomics|February 13, 2010
Cytochrome P450 2C9-CYP2C9Derek Van Booven, Sharon Marsh, Howard McLeod, et al.
Pharmacogenomics|April 29, 2015
Pharmacogenomic assessment of Mexican and Peruvian populationsSharon Marsh, Cristi R King, Derek J Van Booven, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2004
ABCG2 pharmacogenetics: ethnic differences in allele frequency and assessment of influence on irinotecan dispositionFloris A de Jong, Sharon Marsh, Ron H J Mathijssen, et al.
Genomics|October 12, 2004
Pharmacogenomic assessment of carboxylesterases 1 and 2Sharon Marsh, Ming Xiao, Jinsheng Yu, et al.
Clinical Pharmacology and Therapeutics|July 2, 2004
Diflomotecan pharmacokinetics in relation to ABCG2 421C>A genotypeAlex Sparreboom, Hans Gelderblom, Sharon Marsh, et al.
Oncology Reports|April 12, 2011
The NQO1*2/*2 polymorphism is associated with poor overall survival in patients following resection of stages II and IIIa non-small cell lung cancerJill M Kolesar, Suzanne E Dahlberg, Sharon Marsh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2003
Irinotecan pathway genotype analysis to predict pharmacokineticsRon H J Mathijssen, Sharon Marsh, Mats O Karlsson, et al.
Pharmacogenetics and Genomics|April 3, 2009
Association of thymidylate synthase variants with 5-fluorouracil cytotoxicityEric J Peters, Aldi T Kraja, Shiow J Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2006
DNA repair pathway profiling and microsatellite instability in colorectal cancerJinsheng Yu, Mary A Mallon, Wanghai Zhang, et al.
Pageof 9